CHAPTER I ANNUAL PROGRAMMES

Article 1 Bovine brucellosis
1 The programmes for the eradication of bovine brucellosis submitted by Spain, Italy, Malta, Cyprus, Portugal and the United Kingdom are hereby approved for the period from 1 January 2010 to 31 December 2010.
2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests, the compensation to owners for the value of their animals slaughtered subject to those programmes and the purchase of vaccine doses, and shall not exceed:
(a) EUR 2 000 000 for Spain;
(b) EUR 3 600 000 for Italy;
Substituted by Commission Decision of 30 November 2010 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2010 and amending Decision 2009/883/EC as regards the financial contribution by the Union for programmes approved by that Decision (notified under document C(2010) 8290) (2010/732/EU).
(c) EUR 75 000 for Cyprus;
(d) EUR 15 000 for Malta;
(e) EUR 1 200 000 for Portugal;
(f) EUR 1 700 000 for the United Kingdom.
3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for a rose bengal test
EUR 0,2 per test;

(b) for a SAT test
EUR 0,2 per test;

(c) for a complement fixation test
EUR 0,4 per test;

(d) for an ELISA test
EUR 1 per test;

(e) for animals slaughtered
EUR 375 per animal.

Article 2 Bovine tuberculosis
1 The programmes for the eradication of bovine tuberculosis submitted by Ireland, Spain, Italy, Portugal and the United Kingdom are hereby approved for the period from 1 January 2010 to 31 December 2010.
2 The financial contribution by the Union shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the costs of carrying out tuberculin and laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:
(a) EUR 12 500 000 for Ireland;
(b) EUR 10 100 000 for Spain;
(c) EUR 2 800 000 for Italy;
(d) EUR 1 000 000 for Portugal;
(e) EUR 27 000 000 for the United Kingdom.
3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for a tuberculin test
EUR 1,75 per test;

(b) for a gamma-interferon test
EUR 5 per test;

(c) for animals slaughtered
EUR 375 per animal.

Article 3 Ovine and caprine brucellosis
1 The programmes for the eradication of ovine and caprine brucellosis submitted by Spain, Italy, Cyprus and Portugal are hereby approved for the period from 1 January 2010 to 31 December 2010.
2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the purchase of vaccines, the cost of carrying out laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:
(a) EUR 3 000 000 for Spain;
(b) EUR 3 500 000 for Italy;
(c) EUR 75 000 for Cyprus;
(d) EUR 1 100 000 for Portugal.
3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for a rose bengal test
EUR 0,2 per test;

(b) for a complement fixation test
EUR 0,4 per test;

(c) for animals slaughtered
EUR 50 per animal.

Article 4 Bluetongue in endemic or high risk areas
1 The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January to 31 December 2010.
2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out the vaccination, the laboratory tests for virological, serological and entomological surveillance and the purchase of traps and vaccines and shall not exceed:
(a) EUR 4 500 000 for Belgium;
(b) EUR 6 000 for Bulgaria;
(c) EUR 1 650 000 for the Czech Republic;
(d) EUR 50 000 for Denmark;
(e) EUR 1 700 000 for Germany;
(f) EUR 130 000 for Estonia;
(g) EUR 80 000 for Ireland;
(h) EUR 70 000 for Greece;
(i) EUR 19 000 000 for Spain;
(j) EUR 33 500 000 for France;
(k) EUR 2 700 000 for Italy;
(l) EUR 20 000 for Latvia;
(m) EUR 10 000 for Lithuania;
(n) EUR 300 000 for Luxembourg;
(o) EUR 70 000 for Hungary;
(p) EUR 4 000 for Malta;
(q) EUR 130 000 for the Netherlands;
(r) EUR 1 000 000 for Austria;
(s) EUR 70 000 for Poland;
(t) EUR 2 100 000 for Portugal;
(u) EUR 110 000 for Romania;
(v) EUR 40 000 for Slovenia;
(w) EUR 50 000 for Slovakia;
(x) EUR 20 000 for Finland;
(y) EUR 850 000 for Sweden.
3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:
(a)

for an ELISA test
EUR 2,5 per test;
(b)

for a PCR test
EUR 10 per test;
(c)

for the purchase of monovalent vaccines
EUR 0,3 per dose;
(d)

for the purchase of bivalent vaccines
EUR 0,45 per dose;
(e) for the administration of vaccines to bovine animals EUR 1,50 per bovine animal vaccinated, regardless of the number and types of doses used;
(f) for the administration of vaccines to ovine or caprine animals EUR 0,75 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.

Article 5 Salmonellosis (zoonotic salmonella) in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo)
1 The programmes for the control of certain zoonotic salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Estonia, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovakia, Slovenia and the United Kingdom are hereby approved for the period from 1 January to 31 December 2010.
2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out bacteriological and serotyping tests in the framework of official sampling, bacteriological tests to verify the efficiency of disinfection, tests for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for Salmonella, the purchase of vaccine doses and the compensation to owners for the value of the culled breeding and laying birds of Gallus gallus and culled breeding turkey birds of Meleagris gallopavo and for destroyed eggs as specified in paragraph 3 and shall not exceed:
(a) EUR 900 000 for Belgium;
(b) EUR 20 000 for Bulgaria;
(c) EUR 2 500 000 for the Czech Republic;
(d) EUR 400 000 for Denmark;
(e) EUR 25 000 for Estonia;
(f) EUR 800 000 for Germany;
(g) EUR 100 000 for Ireland;
(h) EUR 550 000 for Greece;
(i) EUR 1 400 000 for Spain;
(j) EUR 3 500 000 for France;
(k) EUR 900 000 for Italy;
(l) EUR 100 000 for Cyprus;
(m) EUR 50 000 for Latvia;
(n) EUR 10 000 for Lithuania;
(o) EUR 10 000 for Luxembourg;
(p) EUR 2 500 000 for Hungary;
(q) EUR 150 000 for Malta;
(r) EUR 3 500 000 for the Netherlands;
(s) EUR 960 000 for Austria;
(t) EUR 4 600 000 for Poland;
(u) EUR 55 000 for Portugal;
(v) EUR 600 000 for Romania;
(w) EUR 117 000 for Slovenia;
(x) EUR 600 000 for Slovakia;
(y) EUR 80 000 for the United Kingdom.
3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:
(a) for a bacteriological test (cultivation/isolation) EUR 5,0 per test;
(b) for the purchase of Salmonella vaccine dose EUR 0,05 per dose;
(c) for serotyping of relevant isolates of Salmonella spp. EUR 20 per test;
(d) for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a Salmonella-positive flock EUR 5,0 per test;
(e) for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for Salmonella EUR 5 per test;
(f) for the compensation for the value of a parent breeding bird of Gallus gallus culled, EUR 4 per bird;
(g) for the compensation for the value of a commercial laying bird of Gallus gallus culled, EUR 2,20 per bird;
(h) for the compensation for the value of a parent breeding turkey bird of Meleagris gallopavo culled, EUR 12 per bird;
(i) for the compensation for hatching eggs of parent breeding Gallus gallus, EUR 0,20 per hatching egg destroyed;
(j) for the compensation for table eggs of Gallus gallus EUR 0,04 per table egg destroyed;
(k) for the compensation for hatching eggs of parent breeding Meleagris gallopavo, EUR 0,40 per hatching egg destroyed;

Article 6 Classical swine fever and African swine fever
1 The programmes for the control and monitoring of:
(a) Classical swine fever submitted by Bulgaria, Germany, France, Luxembourg, Hungary, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January 2010 to 31 December 2010;
(b) African swine fever submitted by Italy is hereby approved for the period from 1 January 2010 to 31 December 2010.
2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out virological and serological tests of domestic pigs and wild boars and for the programmes submitted by Bulgaria, Germany, France, Romania and Slovakia also at the rate of 50 % of the costs to be incurred for the purchase and distribution of vaccines plus baits for the vaccination of wild boars and shall not exceed:
(a) EUR 120 000 for Bulgaria;
(b) EUR 1 400 000 for Germany;
(c) EUR 720 000 for France;
(d) EUR 110 000 for Italy;
(e) EUR 25 000 for Luxembourg
(f) EUR 550 000 for Hungary;
(g) EUR 1 200 000 for Romania;
(h) EUR 30 000 for Slovenia;
(i) EUR 250 000 for Slovakia.
3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed for an ELISA test EUR 2,5 per test.

Article 7 Swine vesicular disease
1 The programme for the eradication of swine vesicular disease submitted by Italy is hereby approved for the period from 1 January 2010 to 31 December 2010.
2 The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests and shall not exceed EUR 250 000.

Article 8 Avian influenza in poultry and wild birds
1 The survey programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January to 31 December 2010.
2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests and a lump sum for sampling of wild birds, and shall not exceed:
(a) EUR 135 000 for Belgium;
(b) EUR 50 000 from Bulgaria;
(c) EUR 85 000 for the Czech Republic;
(d) EUR 200 000 for Denmark;
(e) EUR 450 000 for Germany;
(f) EUR 10 000 for Estonia;
(g) EUR 110 000 for Ireland;
(h) EUR 70 000 for Greece;
(i) EUR 300 000 for Spain;
(j) EUR 250 000 for France;
(k) EUR 1 300 000 for Italy;
(l) EUR 20 000 for Cyprus;
(m) EUR 60 000 for Latvia;
(n) EUR for 10 000 Luxembourg;
(o) EUR 300 000 for Hungary;
(p) EUR 10 000 for Malta;
(q) EUR 350 000 for the Netherlands;
(r) EUR 55 000 for Austria;
(s) EUR 100 000 for Poland;
(t) EUR 40 000 for Portugal;
(u) EUR 400 000 for Romania;
(v) EUR 40 000 for Slovenia;
(w) EUR 35 000 for Slovakia;
(x) EUR 35 000 for Finland;
(y) EUR 200 000 for Sweden;
(z) EUR 300 000 for the United Kingdom.
3 The maximum of the costs to be reimbursed to the Member States for the tests/sampling covered by the programmes shall on average not exceed:

(a) ELISA test
EUR 2 per test;

(b) agar gel immune diffusion test
EUR 1,2 per test;

(c) HI test for H5/H7
EUR 12 per test;

(d) virus isolation test
EUR 40 per test;

(e) PCR test
EUR 20 per test;

(f) sampling wild birds
EUR 20 per sample.

Article 9 Transmissible spongiform encephalopathies (TSE), bovine spongiform encephalopathy (BSE) and scrapie
1 The programmes for the monitoring of transmissible spongiform encephalopathies (TSE), and for the eradication of bovine spongiform encephalopathy (BSE) and of scrapie submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, and the United Kingdom are hereby approved for the period from 1 January 2010 to 31 December 2010.
2 The financial contribution by the Union shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for carrying out rapid tests in animals as referred to in Article 12 paragraph 2 of Regulation (EC) No 999/2001, Annex III Chapter A Parts I and II points 1 to 5 of Regulation (EC) No 999/2001 and Annex VII to that Regulation, confirmatory tests and primary molecular discriminatory tests as referred to in of Annex X Chapter C point 3(2)(c)(i) of Regulation (EC) No 999/2001 and at the rate of 50 % of the cost incurred by each Member State for the compensation to owners for the value of their animals culled and destroyed in accordance with their BSE and scrapie eradication programmes and at a rate of 50 % of the cost of the analysis of samples for genotyping, and shall not exceed:
(a) EUR 2 340 000 for Belgium;
(b) EUR 440 000 for Bulgaria;
(c) EUR 1 380 000 for the Czech Republic;
(d) EUR 1 420 000 for Denmark;
(e) EUR 11 260 000 for Germany;
(f) EUR 300 000 for Estonia;
(g) EUR 4 700 000 for Ireland;
(h) EUR 2 000 000 for Greece;
(i) EUR 6 480 000 for Spain;
(j) EUR 16 980 000 for France;
(k) EUR 7 210 000 for Italy;
(l) EUR 70 000 for Cyprus;
(m) EUR 360 000 for Latvia;
(n) EUR 700 000 for Lithuania;
(o) EUR 100 000 for Luxembourg;
(p) EUR 1 230 000 for Hungary;
(q) EUR 30 000 for Malta;
(r) EUR 3 370 000 for the Netherlands;
(s) EUR 1 510 000 for Austria;
(t) EUR 4 930 000 for Poland;
(u) EUR 1 640 000 for Portugal;
(v) EUR 1 000 000 for Romania;
(w) EUR 240 000 for Slovenia;
(x) EUR 650 000 for Slovakia;
(y) EUR 610 000 for Finland;
(z) EUR 970 000 for Sweden;
(za) EUR 5 920 000 for the United Kingdom.
3 The financial contribution by the Community to the programmes referred to in paragraph 1 shall be for the tests performed and for the animals culled and destroyed and the maximum amount shall on average not exceed:

(a) for tests carried out in bovine animals
EUR 8 per test;

(b) for tests carried out in ovine and caprine animals
EUR 30 per test;

(c) for confirmatory and primary molecular discriminatory tests
EUR 175 per test;

(d) per genotyping test
EUR 10;

(e) per culled bovine animal
EUR 500;

(f) per culled sheep or goat
EUR 70.

Article 10 Rabies
1 The programmes for the eradication of rabies submitted by Bulgaria, Hungary, Poland, Romania and Slovakia are hereby approved for the period from 1 January 2010 to 31 December 2010.
2 The financial contribution by the Union shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the isolation and characterisation of the rabies virus, the detection of biomarker and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed:
(a) EUR 1 870 000 for Bulgaria;
(b) EUR 680 000 for Hungary;
(c) EUR 7 380 000 for Poland;
(d) EUR 820 000 for Romania;
(e) EUR 490 000 for Slovakia.
3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:
(a) for a serological test: EUR 12 per test;
(b) for a test to detect tetracycline in bone: EUR 12 per test;
(c) for a fluorescent antibody test (FAT): EUR 18 per test.

Article 11 Enzootic bovine leucosis
1 The programmes for the eradication of enzootic bovine leucosis submitted by Estonia, Lithuania, Malta and Poland are hereby approved for the period from 1 January to 31 December 2010.
2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed EUR:
(a) EUR 20 000 for Estonia;
(b) EUR 40 000 for Lithuania;
(c) EUR 500 000 for Malta;
(d) EUR 650 000 for Poland.
3 The maximum of the costs to be reimbursed to the Member States for the programme referred to in paragraph 1 shall on average not exceed:

(a) for an ELISA test
EUR 0,5 per test;

(b) for an agar gel immune diffusion test
EUR 0,5 per test;

(c) for an animal slaughtered
EUR 375 per animal.

Article 12 Aujeszky’s disease
1 The programmes for the eradication of Aujeszky’s disease submitted by Bulgaria, Spain, Hungary and Poland are hereby approved for the period from 1 January 2010 to 31 December 2010.
2 The financial contribution by the Union to the programmes referred to in paragraph 1 shall be at the rate of 50 % of the costs to be incurred by the concerned Member State for the cost of laboratory tests, and shall not exceed:
(a) EUR 25 000 for Bulgaria;
(b) EUR 300 000 for Hungary;
(c) EUR 1 000 000 for Poland;
(d) EUR 700 000 for Spain.
3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed for an ELISA test EUR 1 per test.